<DOC>
	<DOCNO>NCT01934023</DOCNO>
	<brief_summary>This laboratory pilot study explore effect varenicline tartrate long-term potentiation ( LTP ) -like mechanism ( 1 ) motor cortex ( 2 ) dorsolateral prefrontal cortex ( DLPFC ) work memory non-smoking patient schizophrenia healthy control use Paired Associative Stimulation ( PAS ) method . The present study use novel PAS method evaluate effect five dos varenicline ( Champix ) 0.5 mg BID treatment neuroplasticity change work memory 28 non-smokers schizophrenia 28 non-smoking control placebo-controlled , double-blinded , cross-over design . The hypothesis varenicline increase LTP-like facilitation DLPFC compare placebo patient schizophrenia , less null effect healthy control . Likewise , hypothesize varenicline specifically improve work memory patient schizophrenia compare placebo healthy control . We Hypothesize : 1.Patients Schizophrenia ( SCZ ) reduce cortical LTP impair work memory compare healthy control 2 . Sub-chronic varenicline challenge attenuate cortical LTP work memory deficit patient SCZ . 3.Reversal cortical LTP deficit varenicline patient SCZ associate improvement work memory .</brief_summary>
	<brief_title>Effects Varenicline Plasticity Schizophrenia</brief_title>
	<detailed_description>The experimental laboratory study design randomize , double-blinded , placebo-controlled acute treatment trial . Paired Associative Stimulation ( PAS ) -induced cortical evoked activity Working Memory ( WM ) assess healthy non-smokers non-smokers SCZ , five dos varenicline tartrate ( 0.5 mg/dose ) placebo treatment . PAS induce pair transcranial magnetic stimulation peripheral nerve stimulation , 25 msec apart ( hence PAS-25 ) . In part 1 , motor cortex plasticity assess change motor evoke potential comparing pre post PAS tp 120 min PAS . In part 2 , DLPFC evoke cortical activity assess use EEG compare pre post PAS . Effects varenicline PAS-25 WM evaluate use computerized N-back task , assess directly PAS test . The whole experimental session repeat participant twice : varenicline tartrate treatment placebo treatment , two week apart .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>Inclusion Criteria ( Healthy subject Scz ) : Nonsmoker past smoker , abstinent least last 1 year Females potential childbearing must negative serum pregnancy test inclusion . Ability willingness speak English Willingness provide inform consent Adequate hearing visual capacity , correct visual/ hearing aid , right handedness . INCLUSION Criteria ( Scz Only ) : Diagnosis schizophrenia Stable psychotropic drug treatment least past 4 week Clinically stable past 3 month . Exclusion Criteria ( healthy subject SCZ ) : Current smoker abstinent smoker less 1 year Current history drug abuse disorder current elicit drug use Current past history neurological disorder Current past history seizure Any metal implant Mini Mental Status Examination score less 20 Diagnosis bipolar disorder current Major depression episode Electroconvulsive Therapy ( ECT ) within 6 month Varenicline hypersensitivity .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>plasticity , schizophrenia , varenicline , non smoker ,</keyword>
</DOC>